Shield Therapeutics PLC (STX)

Industry Drug Manufacturers - Specialty & Generic

Sell

2.40p

Buy

2.60p

arrow-down-0.125p (-4.76%)

Prices updated at 10 Jan 2025, 16:30 GMT

Prices minimum 15 mins delay

Prices in GBX

Shield Therapeutics PLC is focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals. It is a specialty pharmaceutical company.

FTSE All-Share

-0.92%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

24 Dec 2024

23 Dec 2024

06 Dec 2024

21 Nov 2024

11 Nov 2024

29 Oct 2024

25 Sep 2024

11 Sep 2024

Key dates

	Forecast date
Half yearly results	Sep 2025
Annual general meeting	Jun 2025
Annual report	May 2025
Final results	Apr 2025

	Previous date
Half yearly results	Sep 2024
Annual general meeting	Jun 2024
Annual report	May 2024
Final results	Apr 2024

Company reports

31 Dec 2022

Annual Report

30 Jun 2023

Quarterly Report

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.